|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2000041062 |
|
最近更新日期: Date of Last Refreshed on: |
2020-12-17 05:10:55 |
|
注册时间: Date of Registration: |
2020-12-17 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
慢性疼痛患者的认知能力及其神经机制 |
|
Public title: |
The cognitive function of patients in chronic pain and its mechanism |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
慢性疼痛患者的认知能力及其神经机制 |
|
Scientific title: |
The cognitive function of patients in cronic pain and its mechanism |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张航宾 |
研究负责人: |
何川 |
|
Applicant: |
Hangbin Zhang |
Study leader: |
Chuan He |
|
申请注册联系人电话: Applicant telephone: |
15310405173 |
研究负责人电话: Study leader's telephone: |
139 6210 6994 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
75081113@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
he-chuan@outlook.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
https://www.jsszh.org.cn/ |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
https://www.jsszh.org.cn/ |
|
申请注册联系人通讯地址: |
江苏省吴江区盛泽镇市场西路1399号 |
研究负责人通讯地址: |
江苏省吴江区盛泽镇市场西路1399号 |
|
Applicant address: |
1399 Shichang West Road, Shengze Town, Wujiang District, Jiangsu Province |
Study leader's address: |
1399 Shichang West Road, Shengze Town, Wujiang District, Jiangsu Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
江苏盛泽医院 |
||
|
Applicant's institution: |
Jiangsu Shengze hospital |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
JSSZYY-LLSC-202019 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
江苏盛泽医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Jiangsu Shengze Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2020-07-22 00:00:00 |
||
|
伦理委员会联系人: |
钱涵哲 |
||
|
Contact Name of the ethic committee: |
Qian Hanzhe |
||
|
伦理委员会联系地址: |
江苏省苏州市吴江区盛泽镇市场西路1399号江苏盛泽医院 |
||
|
Contact Address of the ethic committee: |
1399 Shichang West Road, Shengze Town, Wujiang District, Jiangsu Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
江苏盛泽医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Jiangsu Shengze Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
Jiangsu Shengze Hospital, 1399 Shichang Road West, Shengze Town, Wujiang District, Suzhou, Jiangsu |
||||||||||||||||||||||
|
Primary sponsor's address: |
1399 Shichang Road West, Shengze Town, Wujiang District |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
苏州市临床医学专家团队引进项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
The Introduced Project of Suzhou Clinical Medical Expert Team |
||||||||||||||||||||||
|
Target disease: |
chronic pain |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
基础科学研究 |
||||||||||||||||||||||
|
Study type: |
Basic Science |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
(1)探究慢性疼痛患者共情能力表现情况,解释疼痛患者共情能力下降的原因。 (2)探究慢性疼痛患者疼痛对于抑制控制能力的影响。 (3)探究慢性疼痛患者与健康人的电生理信号的静息态功能链接及功率的差异情况。基于脑电的情况,提出未来可能的干预靶点。 |
||||||||||||||||||||||
|
Objectives of Study: |
(1) To investigate the performance of empathy in patients with chronic pain and to explain the reasons for the decline in empathy in patients with pain. (2) To investigate the effect of pain on inhibitory control in chronic pain patients. (3) Investigate the differences in the resting-state functional links and power of electrophysiological signals in chronic pain patients and healthy individuals. Based on the EEG situation, we will propose possible targets for future interventions. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①符合疼痛患者诊断标准患者以及健康被试; |
||||||||||||||||||||||
|
Inclusion criteria |
1. Patients meeting diagnostic criteria for patients with pain and healthy subjects. |
||||||||||||||||||||||
|
排除标准: |
①除常规药物外近期未接受其余疗法 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. recent treatment other than conventional medicine |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2020-12-25 00:00:00至 To 2021-12-25 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2020-12-30 00:00:00 至 To 2021-06-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本研究不需要随机,疼痛患者为患者组,健康被试作为对照组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
This study does not need to be randomized, pain patients are the patient group, and healthy subjects are the control group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
由一人分组以后,由另一人作为主试指导被试完成不同任务,引导问卷填写,实施脑电的。该实验主试并不知道被试属于患者还是健康对照。 |
|
Blinding: |
After being divided into groups by one person, the other person will guide the subjects to complete different tasks, fill out the questionnaire, and complete the EEG assessment. The subject of the experiment did not know whether the subject was a patient or healthy control. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
试验完成后6个月内公开;中国临床试验注册中心 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Within six months after the trial complete;Chinese Clinical Trial Registry |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
由参与研究的主管医师、治疗师以及研究助理进行数据采集,并由受过培训的专人负责填写病例记录表,研究负责人不时监察确认数据填写的正确性;另由受过培训的两位专人进行数据电子化。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection was performed by the participating supervising physicians, therapists, and research assistants, and case record forms were completed by trained personnel. The study leader monitored the data from time to time to confirm that they were filled out correctly; two other trained individuals completed the data electronically. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |